Ainos Inc.
Ainos Inc. (AIMD): 10 pipeline candidates · ~9 mo cash runway. Updated within the last hour.
BioSniper Score
5-factor signal · derived from public data
9.3 months
D/E 2.88 · 0% dilution
Lead: Approved
10 candidates
N/A
10 buys · 9 sells (180d)
A transparent, data-derived signal for Ainos Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$14.0M
Cash
$2.8M
Quarterly Burn
$983K
Runway
9.3 mo
Revenue
$161
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (10 candidates)
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
7
Total value held
$124K
| Holder | Shares | Value |
|---|---|---|
| geode capital management, llc | 53,074 | $74K |
| vanguard capital management llc | 18,562 | $26K |
| vanguard fiduciary trust co | 14,169 | $20K |
| blackrock, inc. | 3,065 | $4K |
| citigroup inc | 501 | $696 |
| ubs group ag | 2 | $3 |
| cwm, llc | 1 | $1 |
Frequently asked questions
How many drug candidates are in Ainos Inc.'s pipeline?
Ainos Inc. (AIMD) has 10 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Ainos Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Ainos Inc. has approximately 9.3 months of cash runway.
What is Ainos Inc.'s market capitalization?
Ainos Inc.'s market capitalization is approximately $14.0M.
Who is the CEO of Ainos Inc.?
Mr. Chun-Hsien Tsai is the chief executive officer of Ainos Inc. (AIMD).
Get the full picture on Ainos Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.